A Multicenter, Post-Marketing Registry Study of COAGADEX® in the Peri-operative Management of Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Factor X (Primary)
- Indications Factor X deficiency
- Focus Therapeutic Use
- Sponsors Bio Products Laboratory
- 28 Feb 2018 Status changed from not yet recruiting to recruiting.
- 11 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.
- 11 Jul 2017 Planned initiation date changed from 1 May 2017 to 1 Dec 2017.